31796-57-3

Basic information

• Product Name: H-ALA-ASN-OH
• Synonyms: L-ALANYL-L-ASPARAGINE;H-ALA-ASN-OH;(S)-2-((S)-2-AMINO-PROPIONYLAMINO)-SUCCINAMIC ACID
• CAS NO: 31796-57-3
• Molecular Formula: C7H13N3O4
• Molecular Weight: 203.2
• Mol File: 31796-57-3.mol

Chemical Properties

• Boiling Point: 595.6°Cat760mmHg
• Flash Point: 314°C
• Appearance: /
• Density: 1.355g/cm³
• Storage Temp.: -15°C
• CAS DataBase Reference: H-ALA-ASN-OH(CAS DataBase Reference)
• NIST Chemistry Reference: H-ALA-ASN-OH(31796-57-3)
• EPA Substance Registry System: H-ALA-ASN-OH(31796-57-3)

Safety Data

• Hazardous Substances Data: 31796-57-3(Hazardous Substances Data)

Usage

Uses

Used in Cancer Treatment:
H-ALA-ASN-OH is used as a therapeutic agent for its potential anticancer properties. It has been studied for its ability to target and inhibit the growth of cancer cells, making it a promising candidate for cancer treatment.
Used in Drug Delivery Systems:
H-ALA-ASN-OH is utilized as a carrier molecule in drug delivery systems to improve the bioavailability and targeting of therapeutic agents. Its ability to encapsulate and protect drugs during delivery enhances the efficacy and safety of various pharmaceuticals.
Used in Peptide Synthesis:
H-ALA-ASN-OH is employed as a building block in the synthesis of peptide-based materials and pharmaceuticals. Its unique properties and versatility make it a valuable component in the development of novel therapeutic agents and biomaterials.
Used in Biochemical Research:
H-ALA-ASN-OH serves as a biochemical reagent in laboratory research, aiding in the study of various biological processes and the development of new diagnostic and therapeutic approaches.
Used in Dietary Supplements:
As a component of dietary protein sources, H-ALA-ASN-OH can be incorporated into supplements to support overall health and well-being. Its presence in dietary proteins contributes to the maintenance of optimal nutritional balance and promotes healthy bodily functions.

Relevant articles and documents

Identification and characterization of prokaryotic dipeptidyl-peptidase 5 from porphyromonas gingivalis

Porphyromonas gingivalis, a Gram-negative asaccharolytic anaerobe, is a major causative organism of chronic periodontitis. Because the bacterium utilizes amino acids as energy and carbon sources and incorporates them mainly as dipeptides, a wide variety of dipeptide production processes mediated by dipeptidyl-peptidases (DPPs) should be beneficial for the organism. In the present study, we identified the fourth P. gingivalis enzyme, DPP5. In a dpp4-7-11-disrupted P. gingivalis ATCC 33277, a DPP7-like activity still remained. PGN-0756 possessed an activity indistinguishable from that of the mutant, and was identified as a bacterial orthologue of fungal DPP5, because of its substrate specificity and 28.5% amino acid sequence identity with an Aspergillus fumigatus entity. P. gingivalis DPP5 was composed of 684 amino acids with a molecular mass of 77,453, and existed as a dimer while migrating at 66 kDa on SDS-PAGE. It preferred Ala and hydrophobic residues, had no activity toward Pro at the P1 position, and no preference for hydrophobic P2 residues, showed an optimal pH of 6.7 in the presence of NaCl, demonstrated Km and kcat/Km values for Lys-Ala-MCA of 688 μM and 11.02 μM-1 s-1, respectively, and was localized in the periplasm. DPP5 elaborately complemented DPP7 in liberation of dipeptides with hydrophobic P1 residues. Examinations of DPP- and gingipain gene-disrupted mutants indicated that DPP4, DPP5, DPP7, and DPP11 together with Arg- and Lys-gingipains cooperatively liberate most dipeptides from nutrient oligopeptides. This is the first study to report that DPP5 is expressed not only in eukaryotes, but also widely distributed in bacteria and archaea.